Surgepays Inc SURG.OQ SURG.O is expected to show a fall in quarterly revenue when it reports results on May 13 for the period ending March 31 2025
The Bartlett Tennessee-based company is expected to report a 61.2% decrease in revenue to $12.179 million from $31.43 million a year ago, according to the mean estimate from 4 analysts, based on LSEG data.
‚ÄčLSEG's mean analyst estimate for Surgepays Inc is for a loss of 23 cents per share.
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 1 "strong buy" or "buy," 1 "hold" and no "sell" or "strong sell."
The mean earnings estimate of analysts was unchanged in the last three months. ‚Äč
Wall Street's median 12-month price target for Surgepays Inc is $6.88‚Äč, above‚Äč its last closing price of $2.78. ‚Äč‚Äč‚Äč
Previous quarterly performance (using preferred earnings measure in US dollars). ‚Äč
QUARTER ENDING
STARMINESMARTESTIMATE¬ģ
LSEG IBES ESTIMATE
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Dec. 31 2024
-0.27
-0.25
-1.02
Missed
-312.1
Sep. 30 2024
-0.24
-0.27
-0.73
Missed
-173.7
Jun. 30 2024
-0.09
-0.07
-0.66
Missed
-842.9‚Äč
Mar. 31 2024
0.14
0.15
0.07
Missed
-53.3
‚Äč‚ÄčDec. 31 2023
0.41
0.41
0.19
Missed
-53.3
Sep. 30 2023
0.28
0.29
0.49
Beat
71.9‚Äč
Jun. 30 2023
0.15
0.16
0.40
Beat
158.1
Mar. 31 2023
-0.03
-0.03
0.31
Beat
1,133.3
This summary was machine generated May 9 at 20:04 GMT. All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)